Why is Shanghai Kehua Bio-Engineering Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -12.94% and Operating profit at -201.50% over the last 5 years
2
The company has declared Negative results for the last 7 consecutive quarters
- NET PROFIT(HY) At CNY -179.3 MM has Grown at -95.91%
- OPERATING CASH FLOW(Y) Lowest at CNY 0.78 MM
- NET SALES(HY) At CNY 803.38 MM has Grown at -11.42%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -9.36%, its profits have fallen by -219.2%
- At the current price, the company has a high dividend yield of 0
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -9.36% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Kehua Bio-Engineering Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai Kehua Bio-Engineering Co., Ltd.
-3.51%
-0.29
36.18%
China Shanghai Composite
13.33%
0.90
14.74%
Quality key factors
Factor
Value
Sales Growth (5y)
-12.94%
EBIT Growth (5y)
-201.50%
EBIT to Interest (avg)
18.99
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.62
Tax Ratio
0.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
35.70%
ROE (avg)
21.44%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.02
EV to EBIT
-3.84
EV to EBITDA
-5.62
EV to Capital Employed
1.02
EV to Sales
1.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-26.55%
ROE (Latest)
-25.17%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
4What is working for the Company
NET PROFIT(HY)
Higher at CNY -179.3 MM
RAW MATERIAL COST(Y)
Fallen by -12.19% (YoY
-21What is not working for the Company
NET PROFIT(HY)
At CNY -179.3 MM has Grown at -95.91%
OPERATING CASH FLOW(Y)
Lowest at CNY 0.78 MM
NET SALES(HY)
At CNY 803.38 MM has Grown at -11.42%
ROCE(HY)
Lowest at -21.38%
DEBT-EQUITY RATIO
(HY)
Highest at -3.66 %
INTEREST(Q)
At CNY 7.09 MM has Grown at 12.61%
Here's what is working for Shanghai Kehua Bio-Engineering Co., Ltd.
Net Profit
Higher at CNY -179.3 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -12.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Kehua Bio-Engineering Co., Ltd.
Net Profit
At CNY -179.3 MM has Grown at -95.91%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 0.78 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
At CNY 7.09 MM has Grown at 12.61%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 803.38 MM has Grown at -11.42%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debt-Equity Ratio
Highest at -3.66 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






